Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Lumos Pharma Inc (LUMO)

Lumos Pharma Inc (LUMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lumos Pharma Inc 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 USA

P: 512-215-2630

Description:

Lumos Pharma Inc. is a clinical stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics for rare and neglected diseases. The company's product pipeline consists of LUM-201 which is in clinical stage. Lumos Pharma Inc., formerly known as NewLink Genetics Corporation, is based in AUSTIN, Texas.

Key Statistics

Overview:

Market Capitalization, $K 35,264
Enterprise Value, $K -59,546
Shares Outstanding, K 8,396
Annual Sales, $ 230 K
Annual Net Income, $ -30,430 K
Last Quarter Sales, $ 500 K
Last Quarter Net Income, $ -7,250 K
60-Month Beta 0.94
% of Insider Shareholders 15.90%
% of Institutional Shareholders 28.36%
Float, K 7,061
% Float 84.10%
Short Volume Ratio 0.25

Growth:

1-Year Return -49.23%
3-Year Return -71.37%
5-Year Return -94.27%
5-Year Revenue Growth -99.36%
5-Year Earnings Growth 86.21%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.86 on 11/14/22
Next Earnings Date 11/16/22
Earnings Per Share ttm -3.40
EPS Growth vs. Prev Qtr 8.51%
EPS Growth vs. Prev Year 4.44%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-9 on 03/19/20

LUMO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.36%
Return-on-Assets % -31.78%
Profit Margin % -13,230.43
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 162.81
Price/Cash Flow N/A
Price/Book 0.55
Book Value/Share 8.06
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar